SEC Form 4 · accession 0001179110-16-023209
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M. Roach
Officer — Senior VP, Development and Chi
Period of report
Apr 18, 2016
Accepted (ET)
Apr 19, 2016 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 18, 2016 | F | 6,206 | $9.69 | D | 158,655 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related exercise and restricted stock agreement, as amended, between Mr. Roach and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.